DFDA

Lisinopril

Treatment for Rheumatic Heart Disease

Typical Dosage: 2.5-40mg daily

Effectiveness
85%
Safety Score
70%
Clinical Trials
1
Participants
100K

Comparative Safety Scale(Higher is safer)

Cyanide☠ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
2.5-40mg daily
Time to Effect
1-2 weeks
Treatment Duration
lifetime
Evidence Quality
HIGH
Number Needed to Treat (NNT)
8(Treat 8 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
200(Treat 200 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$20
Monitoring:$400
Side Effect Mgmt:$50
Total Annual:$470
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$15,000/QALY
QALYs Gained
1.5
Outcome-Based Costs
Cost per Responder
$627
Comparison vs No ACE inhibitor
Cost Difference
+$470/year
More expensive
QALY Difference
+1.50 QALYs
Better outcomes
Dominance
No dominance
Prescription Access Economics
Risk Assessment
Requires Monitoring
Yes
Needs lab work/checkups
Lisinopril Outcomes

for Rheumatic Heart Disease

Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+75%
Common Side Effects
Cough
+15%
Hypotension
+5%
Hyperkalemia
+3%
Angioedema
+0.5%

Sources:

researchgate.net
elsevierpure.com
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov